Established in 2000, PT Frismed Hoslab Indonesia is Indonesia’s market leader on blood banking products. Frismed Hoslab Indonesia’s journey started from distributing medical consumables, since 2003 FHI started to specialize in blood transfusion products. At FHI’s early stage, FHI started to collaborate with DiaMed, Helmer, and SB-Kawasumi. As of 2004, FHI continued its journey to distribute Kubota and Centron. In 2005 and 2007, FHI started to market EKF and LMB products in Indonesia. By 2018, FHI started to distribute Hemocheck and no longer distributed EKF products in Indonesia. In 2021, FHI reached a very important milestone in our journey. FHI started to partner with Grifols for its top-notch Immunohematology product line, Grifols is a USFDA certified company established in 1909.

 

FHI started small, initially almost 100% of FHI’s customer base are blood centers in Indonesian Red Cross (UTD PMI). By 2010, numbers of Hospital Blood Bank and Hospital Blood Centers started to increase significantly. With this positive trend, FHI’s customer base also continue to expand rapidly. FHI is proud to serve more than its 700 customers throughout Indonesia, with most of our customer base are Indonesian Red Cross, Public Hospital, and Private Hospital.

PT Frismed Hoslab Indonesia is the pioneer to introduce Immunohematology with gel test technology in Indonesia.

PT Frismed Hoslab Indonesia is the only company that specializes in everything related to blood banking products. Frismed Hoslab Indonesia continued to strive to offer our extensive network of customers with the best and industry leading products and services with the most competitive pricing.